BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 38475849)

  • 1. Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond.
    Chen S; Rodewald LE; Du AH; Tang S
    Infect Dis Poverty; 2024 Mar; 13(1):25. PubMed ID: 38475849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coverage and challenges of increasing uptake of non-National Immunization Program vaccines in China: a scoping review.
    Jiang M; Chen S; Yan X; Ying X; Tang S
    Infect Dis Poverty; 2023 Dec; 12(1):114. PubMed ID: 38062480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with recommendation behaviors of four non-National Immunization Program vaccines: a cross-sectional survey among public health workers in China.
    Lyu Y; Lai X; Ma Y; Fang H
    Infect Dis Poverty; 2023 Oct; 12(1):91. PubMed ID: 37805654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coverage and Equity of Childhood Vaccines in China.
    Zhang H; Lai X; Mak J; Sriudomporn S; Zhang H; Fang H; Patenaude B
    JAMA Netw Open; 2022 Dec; 5(12):e2246005. PubMed ID: 36484985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization coverage, knowledge, satisfaction, and associated factors of non-National Immunization Program vaccines among migrant and left-behind families in China: evidence from Zhejiang and Henan provinces.
    Zhou Y; Li D; Cao Y; Lai F; Wang Y; Long Q; Zhang Z; An C; Xu X
    Infect Dis Poverty; 2023 Oct; 12(1):93. PubMed ID: 37833775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13-Valent pneumococcal conjugate vaccines vaccination innovative strategy in Weifang City, China: a case study.
    Wang J; Wang Y; Xu R; Zhang T; Jiang Y; Wang Y; Wang Y; Du Y; Sun W; Deng K; Yang W; Wang Z; Feng L; Wang C
    Infect Dis Poverty; 2023 Dec; 12(1):110. PubMed ID: 38037092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving Innovation and Access to Combination Vaccines for Childhood Immunization in China.
    Ma J; Li Z; Sun Y; Liu Z; Dang Y; Huang Y
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea.
    Choe YJ; Yang JJ; Park SK; Choi EH; Lee HJ
    J Korean Med Sci; 2013 Sep; 28(9):1283-8. PubMed ID: 24015031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adding new childhood vaccines to China's National Immunization Program: evidence, benefits, and priorities.
    Zhang H; Lai X; Patenaude BN; Jit M; Fang H
    Lancet Public Health; 2023 Dec; 8(12):e1016-e1024. PubMed ID: 38000881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of non-National Immunization Program vaccination intentions in rural areas of China.
    Wang X; Fan Y; Wang W
    BMC Public Health; 2023 Aug; 23(1):1485. PubMed ID: 37542236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of innovative immunization strategy on PCV13 vaccination coverage among children under 5 years in Weifang city, China: A retrospective study.
    Wang CP; Lin YT; Du YZ; Zhang T; Wang YY; Wang YJ; Wang JC; Xu RY; Wang ZS; Wang Y; Feng LZ
    Vaccine; 2024 Feb; 42(5):1136-1144. PubMed ID: 38267332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Driving more WHO-recommended vaccines in the National Immunization Program: Issues and challenges in China.
    Dai P; Wang Q; Jia M; Leng Z; Xie S; Feng L; Yang W
    Hum Vaccin Immunother; 2023 Dec; 19(1):2194190. PubMed ID: 37099400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The new National Immunization Program 2017-2019 and the Essential Care Levels: what is going to change?].
    De Waure C; Sisti LG; Poscia A; Ricciardi W
    Ig Sanita Pubbl; 2017; 73(5):405-418. PubMed ID: 29433128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing an effective and sustainable national immunisation programme in China: issues and challenges.
    Chen S; Yao L; Wang W; Tang S
    Lancet Public Health; 2022 Dec; 7(12):e1064-e1072. PubMed ID: 36252582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative assessment of immunization coverage of migrant children between national immunization program vaccines and non-national immunization program vaccines in East China.
    Hu Y; Luo S; Tang X; Lou L; Chen Y; Guo J
    Hum Vaccin Immunother; 2015; 11(3):761-8. PubMed ID: 25760670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization delivery in the second year of life in Ghana: the need for a multi-faceted approach.
    Nyaku M; Wardle M; Eng JV; Ametewee L; Bonsu G; Larbi Opare JK; Conklin L
    Pan Afr Med J; 2017; 27(Suppl 3):4. PubMed ID: 29296139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.
    Rodewald LE
    Infect Dis Poverty; 2023 Oct; 12(1):96. PubMed ID: 37845759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
    Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
    Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.